Document Detail


Cost effectiveness of the type II Boston keratoprosthesis.
MedLine Citation:
PMID:  21183944     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Despite demonstrated cost effectiveness, not all corneal disorders are amenable to type I Boston keratoprosthesis (KPro) implantation. This includes patients with autoimmune diseases, such as Stevens-Johnson syndrome/toxic epidermal necrolysis. Type II KPro is implanted through the eyelids in severe dry eye and cicatricial diseases, and its cost effectiveness was sought.
PATIENTS AND METHODS: In a retrospective chart review, 29 patients who underwent type II KPro surgery at the Massachusetts Eye and Ear Infirmary between the years 2000 and 2009 were identified. A total of 11 patients had 5-year follow-up data. Average cost effectiveness was determined by cost-utility analysis, comparing type II KPro surgery with no further intervention.
RESULTS: Using the current parameters, the cost utility of KPro from third-party insurer (Medicare) perspective was 63,196 $/quality-adjusted life year .
CONCLUSION: Efforts to refer those less likely to benefit from traditional corneal transplantation or type I KPro, for type II KPro surgery, may decrease both patient and societal costs.
Authors:
J D Ament; T P Stryjewski; S Pujari; S Siddique; G N Papaliodis; J Chodosh; C H Dohlman
Related Documents :
18341414 - Evaluation of patient perceptions of frenectomy: a comparison of nd:yag laser and conve...
9427084 - Efficacy of a 2-mm spot size lens for the treatment of superficial vascular lesions wit...
16116824 - Cryoultrasound therapy and tendonitis in athletes: a comparative evaluation versus lase...
10727314 - Pendulaser carbon dioxide resurfacing laser versus electrodesiccation with curettage in...
10778624 - Profile of extrahepatic portal venous obstruction in mumbai.
16612704 - Methods for myometrium closure and other factors impacting effects on cesarean section ...
Publication Detail:
Type:  Journal Article     Date:  2010-12-24
Journal Detail:
Title:  Eye (London, England)     Volume:  25     ISSN:  1476-5454     ISO Abbreviation:  Eye (Lond)     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-10     Completed Date:  2011-08-18     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  8703986     Medline TA:  Eye (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  342-9     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA. jaredament@post.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Cohort Studies
Cornea / surgery
Corneal Diseases / economics*,  surgery
Cost-Benefit Analysis
Female
Health Care Costs*
Humans
Male
Middle Aged
Ophthalmologic Surgical Procedures / economics
Prostheses and Implants / economics*
Prosthesis Implantation / economics*
Retrospective Studies
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pattern electroretinogram association with spectral domain-OCT structural measurements in glaucoma.
Next Document:  Prevalence of pinguecula and pterygium in a general population in Spain.